Skip to main content
. 2023 Mar 27;2023(3):CD009885. doi: 10.1002/14651858.CD009885.pub3
Sample calculation
Ethics approval
Comments from trial authors
Key conclusions of trial authors
Comments from review authors
Inclusion of methylphenidate responders only/exclusion of methylphenidate non‐responders/children who have previously experienced adverse events while taking methylphenidate
Any withdrawals due to adverse events
Supplemental information/data received through personal email correspondence with trial authors in *month* 2014